https://pharmadog.xyz/news/205288 pharmadog en 2026-08-07T17:33:09.000Z Senate hearings blame China, not Fauci, for Covid-19 origin delays https://pharmadog.xyz/news/205076 pharmadog en 2026-08-07T16:38:27.000Z EpilepsyGTx appoints Teresa Nunes as chief medical officer https://pharmadog.xyz/news/204983 pharmadog en 2026-08-07T16:35:22.000Z Senate introduces BINSA bill to tighten review of China biotech and pharma transactions https://pharmadog.xyz/news/205077 pharmadog en 2026-08-07T16:31:41.000Z NIH to restrict Pathways to Independence grants to U.S. citizens and permanent residents https://pharmadog.xyz/news/134233 pharmadog en 2026-08-07T16:10:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/204984 pharmadog en 2026-08-07T16:08:57.000Z FDA schedules September advisory panel to review Grail's cancer test after trial miss https://pharmadog.xyz/news/204712 pharmadog en 2026-08-07T15:08:24.000Z BioMarin halts development of BMN401 enzyme therapy after mixed Phase 3 results https://pharmadog.xyz/news/204559 pharmadog en 2026-08-07T15:00:01.000Z Pfizer exec says China's biotech growth will decelerate as firms hit R&D frontier https://pharmadog.xyz/news/204406 pharmadog en 2026-08-07T14:27:00.000Z Company issues corporate announcement on senior employee transaction https://pharmadog.xyz/news/204475 pharmadog en 2026-08-07T14:17:30.000Z Replimune secures FDA approval for Tudriqev, eyes $1.3 bn peak sales in advanced melanoma https://pharmadog.xyz/news/204515 pharmadog en 2026-08-07T14:02:00.000Z Revolution Medicines sees strong demand for pancreatic cancer drug daraxonrasib under compassionate use https://pharmadog.xyz/news/204307 pharmadog en 2026-08-07T13:56:04.000Z Biopharma job postings rise 15% in Q2 as layoffs fall and M&A activity picks up https://pharmadog.xyz/news/204199 pharmadog en 2026-08-07T13:18:05.000Z Eli Lilly and Novo Nordisk win dismissal of antitrust suit by compound pharmacy https://pharmadog.xyz/news/204819 pharmadog en 2026-08-07T13:00:09.000Z FDA grants emergency use authorization for CLiK Extra wound spray to prevent New World screwworm in livestock and wildlife https://pharmadog.xyz/news/204071 pharmadog en 2026-08-07T12:51:05.000Z Replimune secures FDA accelerated approval for melanoma therapy Tudriqev https://pharmadog.xyz/news/204051 pharmadog en 2026-08-07T12:48:29.000Z Intellia identifies HLA allele linked to severe liver enzyme spikes in ATTR gene therapy https://pharmadog.xyz/news/203934 pharmadog en 2026-08-07T12:16:46.000Z Third gender-affirming clinic settles with DOJ as Senate moves to hold Fauci in contempt https://pharmadog.xyz/news/203914 pharmadog en 2026-08-07T12:09:19.000Z Vistagen’s anxiety nasal spray fails to outperform placebo in Phase 2 study https://pharmadog.xyz/news/204091 pharmadog en 2026-08-07T12:00:00.000Z Latigo Biotherapeutics raises $345.6M in IPO to fund non-opioid pain drug pipeline https://pharmadog.xyz/news/203982 pharmadog en 2026-08-07T11:54:00.000Z Senior staff purchase company shares, filing 16/2026 shows insider buying https://pharmadog.xyz/news/203495 pharmadog en 2026-08-07T11:00:07.000Z Johnson & Johnson’s Global Chair of Innovative Medicine Jennifer Taubert Announces Retirement https://pharmadog.xyz/news/204662 pharmadog en 2026-08-07T10:59:00.000Z Ensoma cuts staff again to focus on lead gene therapy for rare immune disease https://pharmadog.xyz/news/204663 pharmadog en 2026-08-07T10:39:00.000Z BlossomHill and Latigo Biotherapeutics raise over 30% beyond IPO targets https://pharmadog.xyz/news/204130 pharmadog en 2026-08-07T08:59:00.000Z BioMarin halts development of BMN 401 after phase 3 miss https://pharmadog.xyz/news/204132 pharmadog en 2026-08-07T08:45:00.000Z Novo Nordisk CFO sees oral Wegovy rollout boosting outlook and remains upbeat on CagriSema https://pharmadog.xyz/news/202963 pharmadog en 2026-08-07T08:39:12.000Z BlossomHill and Latigo close IPO week with $496 million raised https://pharmadog.xyz/news/203007 pharmadog en 2026-08-07T08:30:00.000Z AI will further erode physician autonomy, says former surgeon https://pharmadog.xyz/news/203008 pharmadog en 2026-08-07T08:30:00.000Z Active shooter incident forces CDC staff to shelter in place, highlighting ongoing threats to public health workers https://pharmadog.xyz/news/203009 pharmadog en 2026-08-07T08:30:00.000Z Boston-born biotech founder Felix Wong launches AI-driven startup in California https://pharmadog.xyz/news/204003 pharmadog en 2026-08-07T06:51:00.000Z Roche launches cyclospora PCR tests as lettuce-linked outbreak spreads across 15 US states https://pharmadog.xyz/news/200611 pharmadog en 2026-08-06T21:00:00.000Z Replimune's oncolytic virus therapy Tudriqev receives FDA accelerated approval for advanced melanoma https://pharmadog.xyz/news/200571 pharmadog en 2026-08-06T20:32:40.000Z Replimune’s Tudriqev immunotherapy receives FDA accelerated approval for advanced melanoma https://pharmadog.xyz/news/200359 pharmadog en 2026-08-06T20:03:38.000Z Replimune secures FDA accelerated approval for melanoma therapy after two prior rejections https://pharmadog.xyz/news/200423 pharmadog en 2026-08-06T19:59:28.000Z FDA grants accelerated approval to Replimune’s melanoma therapy Tudriqev after two prior rejections https://pharmadog.xyz/news/200699 pharmadog en 2026-08-06T19:56:59.000Z FDA grants accelerated approval to Tudriqev viral therapy for PD-1-refractory advanced melanoma https://pharmadog.xyz/news/200360 pharmadog en 2026-08-06T19:16:03.000Z FDA outlines pilot to speed IND submissions for up to 10 drug programs https://pharmadog.xyz/news/200231 pharmadog en 2026-08-06T19:04:09.000Z Teva agrees to $35 million settlement over delayed generic asthma inhalers https://pharmadog.xyz/news/200275 pharmadog en 2026-08-06T19:00:00.000Z Medicare delay adds seven years before AbbVie drug price talks, advocacy group says https://pharmadog.xyz/news/200255 pharmadog en 2026-08-06T18:31:27.000Z BioVie shares plunge as Parkinson’s trial results lack primary motor data https://pharmadog.xyz/news/200295 pharmadog en 2026-08-06T18:07:00.000Z Tarsus to acquire eye-drug startup Alkeus in up to $800 million deal https://pharmadog.xyz/news/203865 pharmadog en 2026-08-06T16:47:00.000Z BioNTech appoints former Sobi chief Guido Oelkers as new CEO https://pharmadog.xyz/news/199831 pharmadog en 2026-08-06T16:08:48.000Z FDA approves Takeda’s orexin-2 drug Orzeyful for narcolepsy type 1 https://pharmadog.xyz/news/199727 pharmadog en 2026-08-06T15:33:40.000Z Intellia finds genetic marker linked to liver enzyme spikes in CRISPR ATTR amyloidosis trial https://pharmadog.xyz/news/199663 pharmadog en 2026-08-06T15:12:00.000Z Erica Schwartz confirmed as CDC director after year-long leadership void https://pharmadog.xyz/news/199643 pharmadog en 2026-08-06T15:00:00.000Z Study uncovers tau’s role in reversing mitochondrial electron flow, offering new Alzheimer’s drug target https://pharmadog.xyz/news/199491 pharmadog en 2026-08-06T14:24:21.000Z Centene reports strong enrollment growth but modest scale for its ICHRA offering https://pharmadog.xyz/news/199515 pharmadog en 2026-08-06T14:24:02.000Z Braveheart Bio targets $382 million IPO to fund cardiac drug development https://pharmadog.xyz/news/199303 pharmadog en 2026-08-06T13:55:00.000Z Sarepta delays Elevidys study readout while Emergent cuts 90 jobs https://pharmadog.xyz/news/199367 pharmadog en 2026-08-06T13:49:23.000Z FDA approves Takeda’s narcolepsy drug and the first mRNA flu vaccine https://pharmadog.xyz/news/199368 pharmadog en 2026-08-06T13:47:31.000Z US moves to shut Kentucky organ donation nonprofit over safety failures https://pharmadog.xyz/news/199369 pharmadog en 2026-08-06T13:38:24.000Z Experts call for independent 9/11‑style commission to review U.S. Covid response https://pharmadog.xyz/news/199239 pharmadog en 2026-08-06T13:17:00.000Z LifeMine secures $263M to advance fungal-derived organ transplant drug https://pharmadog.xyz/news/199347 pharmadog en 2026-08-06T13:13:11.000Z Takeda receives FDA approval for Orzeyful, first orexin agonist to treat all symptoms of narcolepsy type 1 https://pharmadog.xyz/news/199219 pharmadog en 2026-08-06T13:12:35.000Z Senate committee votes to hold Dr. Fauci in contempt over Covid testimony https://pharmadog.xyz/news/199220 pharmadog en 2026-08-06T13:03:26.000Z FDA approves Moderna's mRNA flu vaccine for older adults, first of its kind https://pharmadog.xyz/news/199175 pharmadog en 2026-08-06T12:57:19.000Z Tarsus Pharma to spend $450M upfront acquiring Alkeus to expand its ophthalmology pipeline https://pharmadog.xyz/news/199221 pharmadog en 2026-08-06T12:54:43.000Z Medicare advances ACCESS pilot but leaves patients unaware of participating providers https://pharmadog.xyz/news/199199 pharmadog en 2026-08-06T12:24:15.000Z Sanofi pauses Phase 2 bronchiectasis study of SAR445399 amid new CEO’s portfolio review https://pharmadog.xyz/news/198943 pharmadog en 2026-08-06T12:10:18.000Z FDA approves first mRNA seasonal flu vaccine, mFlusiva, a year after funding cuts https://pharmadog.xyz/news/198944 pharmadog en 2026-08-06T11:55:38.000Z CDC appoints Erica Schwartz as director and Moderna secures approval for mRNA flu vaccine https://pharmadog.xyz/news/198923 pharmadog en 2026-08-06T11:46:14.000Z Moderna's mRNA flu vaccine mFLUVISA receives FDA approval after earlier filing refusal https://pharmadog.xyz/news/198879 pharmadog en 2026-08-06T11:30:19.000Z Merck KGaA to receive up to €40 million in US tariff refunds for life science business through 2026 https://pharmadog.xyz/news/198924 pharmadog en 2026-08-06T11:21:29.000Z LifeMine Therapeutics secures $263 million in dual venture rounds to advance organ transplant aftercare drug https://pharmadog.xyz/news/198815 pharmadog en 2026-08-06T11:10:00.000Z FDA approves Moderna's first mRNA flu vaccine for adults 50 and older https://pharmadog.xyz/news/198751 pharmadog en 2026-08-06T11:00:43.000Z Vedanta Biosciences secures $60 million to complete Phase 3 trial of C. difficile microbiome therapy https://pharmadog.xyz/news/198834 pharmadog en 2026-08-06T11:00:00.000Z Tiziana Life Sciences CEO Ivor Elrifi buys 321,423 shares, raising his stake to 4.79 million https://pharmadog.xyz/news/201350 pharmadog en 2026-08-06T11:00:00.000Z Tiziana Life Sciences CEO Ivor Elrifi boosts stake, buying 321,423 shares at $1 each https://pharmadog.xyz/news/199575 pharmadog en 2026-08-06T10:34:00.000Z Vistagen's anxiety nasal spray fails to outperform placebo in phase 2 trial https://pharmadog.xyz/news/198752 pharmadog en 2026-08-06T10:30:08.000Z LifeMine Therapeutics secures $263 million to develop safer transplant immunosuppressant https://pharmadog.xyz/news/198796 pharmadog en 2026-08-06T10:30:00.000Z Tenax Therapeutics to Release Phase 3 Heart Failure Trial Results Soon https://pharmadog.xyz/news/198795 pharmadog en 2026-08-06T10:30:00.000Z Biotech leader Greg Verdine enjoys a successful year with multiple wins https://pharmadog.xyz/news/198775 pharmadog en 2026-08-06T10:17:07.000Z Podcast explores emerging rapid‑acting and psychedelic therapies for treatment‑resistant depression https://pharmadog.xyz/news/199467 pharmadog en 2026-08-06T10:07:00.000Z Tarsus to acquire Alkeus for $450 million, adding phase-3 retinal drug and oral Stargardt candidate https://pharmadog.xyz/news/199466 pharmadog en 2026-08-06T10:02:00.000Z PacBio appoints COO Mark Van Oene as new CEO after Christian Henry steps down https://pharmadog.xyz/news/199468 pharmadog en 2026-08-06T09:40:00.000Z BioVie’s Parkinson drug data prompts 50% stock drop as company shifts to composite endpoint https://pharmadog.xyz/news/198372 pharmadog en 2026-08-06T08:30:00.000Z AI’s role in medicine isn’t monolithic, says industry leader, urging nuanced adoption https://pharmadog.xyz/news/198371 pharmadog en 2026-08-06T08:30:00.000Z U.S. experts to evaluate if measles elimination status still holds amid rising cases https://pharmadog.xyz/news/198094 pharmadog en 2026-08-06T07:31:00.000Z InstallatørGruppen reports insider share transaction involving board members' associate https://pharmadog.xyz/news/201351 pharmadog en 2026-08-06T07:31:00.000Z InstallatørGruppen reports share transaction by board linked entity Absalon Holdings https://pharmadog.xyz/news/198095 pharmadog en 2026-08-06T07:18:00.000Z Novo Nordisk reports board and executive share transactions under EU market abuse rules https://pharmadog.xyz/news/201352 pharmadog en 2026-08-06T07:18:00.000Z Novo Nordisk board members disclose share vesting transactions https://pharmadog.xyz/news/197927 pharmadog en 2026-08-06T07:00:00.000Z BioSpace lists top 12 biopharma employers hiring in July 2026 https://pharmadog.xyz/news/197928 pharmadog en 2026-08-06T07:00:00.000Z Choosing Between CROs and Biotechs: How Company Size Shapes the Fit https://pharmadog.xyz/news/197903 pharmadog en 2026-08-06T06:56:05.000Z Braveheart Bio raises $383 million in Nasdaq IPO to advance Hengrui cardiovascular drug to Phase 3 https://pharmadog.xyz/news/198727 pharmadog en 2026-08-06T05:56:00.000Z Context Therapeutics drops CT-95 bispecific T-cell engager to stretch cash runway to 2027 https://pharmadog.xyz/news/199151 pharmadog en 2026-08-06T05:09:00.000Z Actimed regains full rights to S-oxprenolol, ends $126 million Faraday licensing deal https://pharmadog.xyz/news/199150 pharmadog en 2026-08-06T04:19:00.000Z Braveheart Bio raises $382.5M in IPO to fund phase 3 trial of cardiac drug https://pharmadog.xyz/news/200790 pharmadog en 2026-08-06T04:00:00.000Z Medline recalls Hudson RCI neonatal heated wire breathing circuits over connector overheating risk https://pharmadog.xyz/news/197163 pharmadog en 2026-08-06T02:25:52.000Z FDA approves Moderna flu vaccine https://pharmadog.xyz/news/197207 pharmadog en 2026-08-06T02:18:37.000Z FDA approves Moderna's first mRNA flu vaccine for seniors https://pharmadog.xyz/news/196975 pharmadog en 2026-08-06T01:31:29.000Z Revolution Medicines readies launch of experimental pancreatic cancer drug daraxonrasib as approval decision pending https://pharmadog.xyz/news/197227 pharmadog en 2026-08-06T00:01:00.000Z Cardiac biotech Braveheart raises $382.5M in IPO, launches on Nasdaq as BRVE https://pharmadog.xyz/news/201758 pharmadog en 2026-08-06T00:00:00.000Z FDA approves first drug for type 1 narcolepsy and greenlights mRNA flu vaccine; AstraZeneca and BMS deny merger talks https://pharmadog.xyz/news/201757 pharmadog en 2026-08-06T00:00:00.000Z EMA launches consultation to streamline nonclinical development for life-threatening diseases https://pharmadog.xyz/news/201756 pharmadog en 2026-08-06T00:00:00.000Z FDA says MDUFA VI will prioritize review consistency and domestic focus over faster timelines